Ineffective neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine sera

Keiya Uriu; Izumi Kimura; Kotaro Shirakawa; Akifumi Takaori-Kondo; Taka-aki Nakada; Atsushi Kaneda; The Genotype to Phenotype Japan (G2P-Japan) Consortium; So Nakagawa; Kei Sato

doi:10.1101/2021.09.06.459005

New Results

Ineffective neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine sera

Keiya Uriu, Izumi Kimura, Kotaro Shirakawa, Akifumi Takaori-Kondo, Taka-aki Nakada, Atsushi Kaneda, The Genotype to Phenotype Japan (G2P-Japan) Consortium, View ORCID ProfileSo Nakagawa, View ORCID ProfileKei Sato

doi: https://doi.org/10.1101/2021.09.06.459005

Keiya Uriu

1Institute of Medical Science, University of Tokyo, Tokyo, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Izumi Kimura

1Institute of Medical Science, University of Tokyo, Tokyo, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kotaro Shirakawa

2Kyoto University, Kyoto, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Akifumi Takaori-Kondo

2Kyoto University, Kyoto, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Taka-aki Nakada

3Chiba University, Chiba, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Atsushi Kaneda

3Chiba University, Chiba, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

So Nakagawa

4Tokai University, Kanagawa, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for So Nakagawa

Kei Sato

1Institute of Medical Science, University of Tokyo, Tokyo, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Kei Sato
For correspondence: KeiSato@g.ecc.u-tokyo.ac.jp

Abstract
Full Text
Info/History
Metrics
Supplementary material
Preview PDF

Supplementary Method and Tables[supplements/459005_file03.pdf]

View the discussion thread.

PreviousNext

Posted September 07, 2021.

Download PDF

Supplementary Material

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Ineffective neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine sera

Message Subject (Your Name) has forwarded a page to you from bioRxiv

Message Body (Your Name) thought you would like to see this page from the bioRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Ineffective neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine sera

Keiya Uriu, Izumi Kimura, Kotaro Shirakawa, Akifumi Takaori-Kondo, Taka-aki Nakada, Atsushi Kaneda, The Genotype to Phenotype Japan (G2P-Japan) Consortium, So Nakagawa, Kei Sato

bioRxiv 2021.09.06.459005; doi: https://doi.org/10.1101/2021.09.06.459005

Share This Article:

Citation Tools

Ineffective neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine sera

Keiya Uriu, Izumi Kimura, Kotaro Shirakawa, Akifumi Takaori-Kondo, Taka-aki Nakada, Atsushi Kaneda, The Genotype to Phenotype Japan (G2P-Japan) Consortium, So Nakagawa, Kei Sato

bioRxiv 2021.09.06.459005; doi: https://doi.org/10.1101/2021.09.06.459005

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Tweet Widget
Facebook Like
Google Plus One

Subject Area

Microbiology

Subject Areas

All Articles

Animal Behavior and Cognition (4102)
Biochemistry (8806)
Bioengineering (6506)
Bioinformatics (23435)
Biophysics (11780)
Cancer Biology (9190)
Cell Biology (13304)
Clinical Trials (138)
Developmental Biology (7427)
Ecology (11399)
Epidemiology (2066)
Evolutionary Biology (15138)
Genetics (10427)
Genomics (14033)
Immunology (9163)
Microbiology (22140)
Molecular Biology (8802)
Neuroscience (47520)
Paleontology (350)
Pathology (1427)
Pharmacology and Toxicology (2488)
Physiology (3728)
Plant Biology (8076)
Scientific Communication and Education (1437)
Synthetic Biology (2220)
Systems Biology (6032)
Zoology (1252)